Analysis Issues for Gene Expression Array Data (Special Report) Analysis Issues for Gene Expression Array Data (Special Report)

Analysis Issues for Gene Expression Array Data (Special Report‪)‬

Clinical Chemistry 2001, August, 47, 8

    • 2,99 €
    • 2,99 €

Publisher Description

Gene expression array technologies are rapidly emerging for use in various genome-wide studies in biology and medicine (1-3). Results from the recently completed sequencing of the human genome predict that the number of genes in the human genome is much smaller (~33 000 genes) than anticipated (4). This implies that the major complexity in biological mechanisms in humans lies in the synergistic effects among various genes. Therefore, to decipher the secrets of our life and, ultimately, to find the cures for many human diseases, biologists must deal with multiple genes and their interactive transcripts simultaneously. High-throughput biotechnologies, including gene chip approaches, will play an important role in these studies (5). However, quality control over thousands of gene expression values and full utilization of the information from these high-throughput data are extremely difficult, and important issues in quality control and bioinformatic approaches have not been resolved (6, 7). A series of careful analyses on the variability of array instrumentation and on the statistical evaluation of gene expression intensities are required for reliable and consistent inference on gene chip data. Specifically, sources of error and their confidence levels on these high-throughput measurements need to be better understood because some can significantly alter our inferences and conclusions (8). The purpose of this report is to dispel three common misconceptions about array experiments.

GENRE
Science & Nature
RELEASED
2001
1 August
LANGUAGE
EN
English
LENGTH
9
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
164.7
KB
Alcohol Abuse and Carbohydrate-Deficient Transferrin Analysis: Are Screening and Confirmatory Analysis Required?(Letters) (Letter to the Editor) Alcohol Abuse and Carbohydrate-Deficient Transferrin Analysis: Are Screening and Confirmatory Analysis Required?(Letters) (Letter to the Editor)
2002
Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report) Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report)
2008
Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and Coagulation Factor XIII Val34leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss (Molecular Diagnostics and Genetics) Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and Coagulation Factor XIII Val34leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss (Molecular Diagnostics and Genetics)
2003
Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology) Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology)
2004
Metabolic, Nutritional, Iatrogenic, And Artifactual Sources of Urinary Organic Acids: A Comprehensive Table. Metabolic, Nutritional, Iatrogenic, And Artifactual Sources of Urinary Organic Acids: A Comprehensive Table.
2002
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997